Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 August 2021 | Story Department of Communication and Marketing

Dear Student, 

As from today (20 August 2021), all people 18 years and older are eligible to be vaccinated against COVID-19. Register on the COVID-19 Vaccination Programme registration portal to get the vaccine.

Individuals aged 18 and older can get vaccinated at sites  across the country – including the Universitas Academic Hospital in Bloemfontein and retail stores such as Clicks and Dischem.

Remember, you can walk into any vaccination site to register and vaccinate. 

Here is a list of registered vaccination sites closest to the University of the Free State campuses: 
- Boikhuco Old Age Home – Bloemfontein (Mangaung)
- MUCPP Community Health Centre in Rocklands – Bloemfontein (Mangaung)x
- Pelonomi Hospital – Bloemfontein (Mangaung) 
- Standard Bank Building – Bloemfontein (Mangaung)
- Universitas Academic Hospital – Bloemfontein (Mangaung)
- Botshabelo Hospital – Botshabelo (Mangaung)
- Seemahale Secondary School – Botshabelo (Mangaung)
- Dr JS Moroka Hospital – Thaba Nchu (Mangaung)
- Dihlabeng Regional Hospital – Bethlehem, Dihlabeng (Thabo Mofutsanyana)
- Thabo Thokoza Secondary School – Dihlabeng (Thabo Mofutsanyana)
- Thekolohelong Old Age Home – Maluti-A-Phofung (Thabo Mofutsanyana)
- Senorita Nthlabathi District Hospital – Mantsopa (Thabo Mofutsanyana)
- Nketoana District Hospital – Nketoana (Thabo Mofutsanyana)
- Phumelela District Hospital – Phumelela (Thabo Mofutsanyana)

Vaccines are an important part of stopping the spread of COVID-19. Vaccines reduce the risk of getting a disease by working with your body to build protection. 

Need more information on vaccines? Read our COVID-19 Vaccine Information booklet here.

Visit the UFS COVID-19 webpage for updated information. 


News Archive

Death may come in adorable little packages
2015-03-23

The main host of the Lassa virus is the Natal Mulimammate mouse.

Photo: Supplied

Postdoctoral researcher, Abdon Atangana, of the Institute for Groundwater Studies at the university recently published an article online about the Lassa Haemorrhagic fever in the Natural Computing Applications Forum. In addition to the terminal transmissible sickness recognised as Ebola haemorrhagic fever, there is another strain called Lassa haemorrhagic fever.

The disease is classified under the arenaviridae virus family. The first outbreaks of the disease were observed in Nigeria, Liberia, Sierra Leone, and the Central African Republic. However, it was first described in 1969 in the town of Lassa, in Borno State, Nigeria.

The main host of the Lassa virus is the Natal Mulimammate mouse, an animal indigenous to most of Sub-Saharan Africa. The contamination in humans characteristically takes place through exposure to animal excrement through the respiratory or gastrointestinal tracts.

Mouthfuls of air containing tiny particle of infective material are understood to be the most noteworthy way of exposure. It is also possible to acquire the infection through broken skin or mucous membranes that are directly exposed to the infective material.

“The aim of my research was to propose a novel mathematical equation used to describe the spread of the illness amongst pregnant women in West Africa. To achieve this, I used my newly-proposed derivative with fractional order called beta-derivative. Since none of the commonly used integral transform could be used to derive the solution of the proposed model, I proposed a new integral transform called Atangana-Transform, and used it, together with some iterative technique, to derive the solution of the model.

“My numerical simulations show that the disease is as deadly amongst pregnant women as Ebola,” Abdon said.

Abdon’s research was submitted to one of Springer’s top-tier journals with an impact factor 1.78. The paper was accepted and published February 2015.

Read more about Abdon’s research.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept